IGF2BP3 and malignant peritoneal mesothelioma: A direct correlation has been reported between the immunohistochemical evaluation of IGF2BP3 expression and increased staining of the proliferation index ki67 in malignant peritoneal mesothelioma (Hui et al., 2018), neuroendocrine tumors of the lung, in which IGF2BP3 was also directly correlated with the stem cell marker Nanog (Del Gobbo et al., 2014), and triple-negative breast carcinoma, in which IGF2BP3 expression was also significantly associated with a poor response to neoadjuvant chemotherapy (Walter et al., 2009; Ohashi et al., 2017).